NASDAQ
PETS
Last Price
US $2.03
KEY FIGURES
MKT CAP
$43.4M
EPS
TTM
$-1.35
EPS Growth (1Y)
813.33%
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.26x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Cash Flow (DCF)
Fair Value
Market $2.03
—
Default assumptions
EBITDA Multiple
Fair Value
Market $2.03
132.02%
Default assumptions
Valuation
Financial
Performance
Cash flow to debt coverage
PetMed Express, Inc. cash flow to debt ratio of -5.31K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
PetMed Express, Inc.'s free cash flow has decreased 8.26K% from $-395.00K last year to $-33.01M, signaling decreasing performance
Debt-to-equity ratio
PetMed Express, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
PetMed Express, Inc.'s debt has increased relative to shareholder equity from 0.01 last year to 0.02 today, signaling weakened financials
Net debt to EBITDA
PetMed Express, Inc. has a net cash position, so leverage is healthy.
Interest coverage
PetMed Express, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
PetMed Express, Inc.'s profit margin has decreased (1.06K%) in the last year from -2.76% to -32.00%, signaling decreasing performance
Current ratio
PetMed Express, Inc.'s short-term liabilities of $52.03M exceed its short-term assets of $43.56M, signaling financial risk
Return on assets
PetMed Express, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
PetMed Express, Inc.'s return on equity of -146.59%, is lower than 15.00%, indicating bad performance
Earnings quality
PetMed Express, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
PetMed Express, Inc. had positive net income in only 2 out of 5 years, indicating unstable earnings
Positive free cash flow
PetMed Express, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
PetMed Express, Inc. has negative free cash flow, indicating cash burn
Earnings growth
PetMed Express, Inc.'s yearly earnings has decreased 813.51% since last year from $-6.27M to $-57.29M, signaling decreasing performance
Revenue growth
PetMed Express, Inc.'s yearly revenue has decreased 21.13% since last year from $226.97M to $179.02M, signaling decreasing performance
Return on invested capital
ROIC -105.82% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
PetMed Express, Inc.'s 3-year revenue CAGR of -11.31% is negative, indicating declining revenue over the past 3 years
Revenue consistency
PetMed Express, Inc. had revenue growth in only 1 out of 5 years, indicating inconsistent revenue performance
Return on equity consistency
PetMed Express, Inc. had positive ROE in only 2 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
PetMed Express, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
PetMed Express, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
PetMed Express, Inc. is undervalued relative to its fair value price of 4.71 based on EBITDA multiple model
EV/EBITDA (FY)
PetMed Express, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
PetMed Express, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
PetMed Express, Inc. has a price-to-book ratio of 1.43x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
PetMed Express, Inc. has a price-to-sales ratio of 0.23x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-6.90%
Return on equity
ROIC: -7.26%
Valuation History
-
Price to Earnings
EV/EBITDA: 4.9X
Cash flow
Profit margin
-10.02%
EBITDA
-
Cash flow
-
EARNINGS FV (GRAHAM)
Fair Value
Market $2.03
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.